Gan & Lee Pharma, IDF partner to promote diabetes care and prevention worldwide

Gan & Lee Pharmaceuticals Co Ltd, a global biopharmaceutical company, has announced a Collaborating association with the International Diabetes Federation (IDF) that seeks to support its global effort to promote diabetes care and prevention worldwide. This collaboration will enable support opportunities that are compatible with future initiatives, such as medical education through the IDF School of Diabetes and being inaugural partners in the launch of the IDF WeChat platform in China. This association will provide the opportunity to participate in advocacy initiatives, such as World Diabetes Day and the Centenary of Insulin.

“Gan & Lee’s collaboration with the IDF will provide an opportunity to support global outreach and advocacy initiatives that help improve the lives of people affected by diabetes,” said Kai Du, CEO of Gan & Lee. Pharmaceuticals and president of Gan & Lee USA Corporation.

Diabetes care is multidimensional due to complex interactions between environmental, lifestyle, clinical, and genetic factors. These unique complications, along with continued access to treatment, training, and medication, strongly influence the clinical course. According to the latest edition of the IDF Diabetes Atlas, some 463 million adults (ages 20 to 79) are living with diabetes in 2019, and this number is expected to grow to 700 million by 2045. Additionally, 1 in 2 people with diabetes in 2019 were undiagnosed. Gan & Lee knows the importance of supporting online learning with resource and advocacy initiatives for people affected by diabetes.

“The International Diabetes Federation is pleased to welcome Gan & Lee as a partner to support our global awareness, advocacy and training initiatives. In a year that marks the centenary of the discovery of insulin, coordinated and collaborative action to ensure cost-effective and uninterrupted care for each person with diabetes, regardless of where they live or their financial circumstances, is more important than ever, “said Professor Andrew Boulton, CEO of the International Diabetes Federation.